ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 255111 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 255111; 2) Community: the network communities that were significantly associated with the response to NSC 255111; 3) Molecule: the relationships between components within communities and NSC 255111; 4) MDR: the compounds that were significantly associated with the NSC 255111.

NSC Compound Enrichment Correlation
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.00126952303154153 0.34526778
NSC 169774 Bromocriptine methanesulfonate 0.00126952303154154 0.31911254
NSC 638265 Null 0.00134950525162029 0.65084971
NSC 351078 Hydrazinecarbothioamide, N,N-dimethyl-2-[1-(2-pyridinyl)- ethylidene]-, N-oxide 0.00176785174089477 0.44941698
NSC 373980 Null 0.00176785174089477 0.37547965
NSC 380721 Eremantholide B 0.00176785174089477 0.41847509
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.00176785174089477 0.41016543
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.00176785174089477 0.47549454
NSC 630511 1,4-Benzoquinone-2-methoxy-5-dimethylaminomethyl- 6-(10-heptadecenyl)-(Z)-, hydrochloride 0.00176785174089477 0.49877148
NSC 633203 Null 0.00176785174089477 -0.28634151
Total:157  Current:17    [First] [Prev] [Next] [Last]